High materiality7/10
First Tracks Biotherapeutics price target raised to $95 from $54 at Piper Sandler
Why it may matterVerify against the original reporting
Upside potential from higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raises TRAX target to $95; current price $46.13.
- TRAX target raised to $95 by Piper Sandler; price $46.13.
Key facts
- 01
Target: $95
- 02
Posted price: $46.13
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.